Cargando…

Zika and Chikungunya Virus and Risk for Venous Thromboembolism

A variety of viral infections are associated with hypercoagulable states and may be linked to the development of deep venous thrombosis and pulmonary embolism. The Zika and Chikungunya viral infections spread through the South and Central American continents, moving to North America in 2016, with se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramacciotti, Eduardo, Agati, Leandro B., Aguiar, Valéria C. R., Wolosker, Nelson, Guerra, João C., de Almeida, Roque P., Alves, Juliana Cardoso, Lopes, Renato D., Wakefield, Thomas W., Comerota, Anthony J., Walenga, Jeanine, Fareed, Jawed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714924/ https://www.ncbi.nlm.nih.gov/pubmed/30808213 http://dx.doi.org/10.1177/1076029618821184

Ejemplares similares

Why differentiate low molecular weight heparins for venous thromboembolism?
por: Fareed, Jawed, et al.
Publicado: (2007)

Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019?
por: Ramacciotti, Eduardo, et al.
Publicado: (2019)

Edoxaban for Venous Thromboembolism Treatment—The New Kid on The Block for Latin America. A Practical Guide
por: Ramacciotti, Eduardo, et al.
Publicado: (2018)

Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism
por: Fareed, Jawed, et al.
Publicado: (2011)

Update on the safety and bioequivalence of biosimilars – focus on enoxaparin
por: Jeske, Walter, et al.
Publicado: (2013)

The Risk of Venous Thromboembolism is Not Equal for all Patients Who Undergo Total Joint Replacement
por: Tafur, Alfonso, et al.
Publicado: (2019)

Heparan sulphate inhibition of cell proliferation induced by TGFβ and PDGF
por: Silber, lan E., et al.
Publicado: (1993)

Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial: Venous thromboembolism prophylAxis after gynecoLogical pElvic cancer surgery with RIvaroxaban versus enoxAparin (VALERIA trial)
por: Longo de Oliveira, André Luiz Malavasi, et al.
Publicado: (2022)

An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination
por: Kantarcioglu, Bulent, et al.
Publicado: (2021)

Porcine Mucosal Heparin Shortage Crisis! What Are the Options?
por: Fareed, Jawed, et al.
Publicado: (2019)

Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients
por: Otasevic, Vladimir, et al.
Publicado: (2022)

Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism
por: Siddiqui, Fakiha, et al.
Publicado: (2022)

Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar Version
por: Qneibi, Dalia, et al.
Publicado: (2020)

Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro-Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism
por: O’Hara, Alexander, et al.
Publicado: (2023)

Intermittent pneumatic compression is a cost-effective method of orthopedic postsurgical venous thromboembolism prophylaxis
por: Saunders, Rhodri, et al.
Publicado: (2018)

Impact of concurrent epidemics of dengue, chikungunya, zika, and COVID-19
por: Vicente, Creuza Rachel, et al.
Publicado: (2021)

Chikungunya, Dengue, and Zika in Immunocompromised Hosts
por: Darrigo, Luiz Guilherme, et al.
Publicado: (2018)

Cost-effectiveness analysis of extended thromboprophylaxis with rivaroxaban versus no prophylaxis in high-risk patients after hospitalisation for COVID-19: an economic modelling study
por: Carvalho de Oliveira, Caroline Cândida, et al.
Publicado: (2023)

Chikungunya and Zika Viruses: Global Emerging Health Threats
por: Blitvich, Bradley J., et al.
Publicado: (2018)

Dengue, chikungunya and zika arbovirus infections in Caribbean children
por: Christie, Celia D.C., et al.
Publicado: (2023)

Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values
por: Siddiqui, Fakiha, et al.
Publicado: (2019)

The Challenges Imposed by Dengue, Zika, and Chikungunya to Brazil
por: Zanotto, Paolo Marinho de Andrade, et al.
Publicado: (2018)

Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin at USP Potency Adjusted Levels
por: Jeske, Walter, et al.
Publicado: (2019)

Dengue, Yellow Fever, Zika and Chikungunya epidemic arboviruses in Brazil: ultrastructural aspects
por: Barreto-Vieira, Debora Ferreira, et al.
Publicado: (2021)

Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial
por: Ramacciotti, Eduardo, et al.
Publicado: (2022)

Dengue, Zika and Chikungunya: Emerging Arboviruses in the New World
por: Patterson, Jessica, et al.
Publicado: (2016)

Antibody seropositivity and endemicity of chikungunya and Zika viruses in Nigeria
por: Mac, Peter Asaga, et al.
Publicado: (2023)

Aedes hensilli as a Potential Vector of Chikungunya and Zika Viruses
por: Ledermann, Jeremy P., et al.
Publicado: (2014)

Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism
por: Kantarcioglu, Bulent, et al.
Publicado: (2022)

Outbreak of Exanthematous Illness Associated with Zika, Chikungunya, and Dengue Viruses, Salvador, Brazil
por: Cardoso, Cristiane W., et al.
Publicado: (2015)

Can We Improve on the Rapid Assessment of Clinically Relevant Levels of Direct Acting Oral Anticoagulants (DOAC)?
por: Walenga, Jeanine M.
Publicado: (2022)

Venous thromboembolism prophylaxis on flights
por: Marques, Marcos Arêas, et al.
Publicado: (2018)

Sequential Infection of Aedes aegypti Mosquitoes with Chikungunya Virus and Zika Virus Enhances Early Zika Virus Transmission
por: Magalhaes, Tereza, et al.
Publicado: (2018)

Metabolomic Insights into Human Arboviral Infections: Dengue, Chikungunya, and Zika Viruses
por: Byers, Nathaniel M., et al.
Publicado: (2019)

Dengue, chikungunya and Zika virus infections among Dutch travellers to Suriname: a prospective study during the introduction of chikungunya and Zika virus, 2014 to 2017
por: Overbosch, Femke W, et al.
Publicado: (2023)

Dengue, chikungunya and zika virus coinfection: results of the national surveillance during the zika epidemic in Colombia
por: Mercado-Reyes, Marcela, et al.
Publicado: (2019)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
por: Puhr, Hannah C., et al.
Publicado: (2019)

In vitro study of Hesperetin and Hesperidin as inhibitors of zika and chikungunya virus proteases
por: Eberle, Raphael J., et al.
Publicado: (2021)

Dengue, West Nile virus, chikungunya, Zika—and now Mayaro?
por: Hotez, Peter J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fuhu2a3jg2ab8479to9313bnrp